A community-based study of the effectiveness of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) on quality of life and satisfaction with treatment in participants with rosacea.

Cutis; cutaneous medicine for the practitioner

Volumn 86, Issue 5 Suppl, 2010, Pages 26-36

  Baldwin, Hilary E ^a  

^a State University of New York Downstate Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DOXYCYCLINE;

ARTICLE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; DELAYED RELEASE FORMULATION; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NONPARAMETRIC TEST; ORAL DRUG ADMINISTRATION; PATIENT SATISFACTION; PHASE 4 CLINICAL TRIAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; ROSACEA;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; CHI-SQUARE DISTRIBUTION; DELAYED-ACTION PREPARATIONS; DOXYCYCLINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; ROSACEA; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 79952254767     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)